Enapter AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG ...
Original-Research: MWB AG (von NuWays AG): HOLD
Original-Research: Desert Gold Ventures Inc. (von GBC AG): ...
CanAlaska Uranium sichert bis zu 15 Millionen Kanadische ...
IperionX-Direktor Todd Hannigan investiert 1 5 Millionen ...
NurExone zeigt reproduzierbare dosisabhängige Wiederherstellung ...
Camino erhält Genehmigung für eine erweiterte Abraumhalde ...
Original-Research: Somec S.p.A. (von GBC AG): BUY
Diginex gibt den Abschluss der Übernahme von Matter DK ...
Original-Research: Swissnet AG (von NuWays AG): BUY
Samsung Electronics beendet erfolgreich Aktienrückkauf ...
it-sa 2025: ESET veröffentlicht Ransomware-Paper mit Trends ...
Original-Research: Westwing Group SE (von NuWays AG): BUY ...
Der britische Transportkonzern FirstGroup hat weitere eigene ...
Der Vanguard Information Technology ETF verzeichnet starke ...
Original-Research: q.beyond AG (von NuWays AG): BUY
Bio-Gate veröffentlicht Halbjahreszahlen und bestätigt ...
EQS-Stimmrechte: AT&S Austria Technologie & Systemtechnik ...
AT&S Austria Technologie & Systemtechnik AG: Korrektur - ...
Original-Research: UmweltBank AG (von GBC AG): BUY
Original-Research: Deutsche Beteiligungs AG (von NuWays ...
EQS-News: Ottobock legt Preisspanne für geplanten Börsengang ...
Ottobock legt Preisspanne für geplanten Börsengang fest ...
EQS-HV: Haier Smart Home Co. Ltd: Bekanntmachung der Einberufung ...
Sector Under Pressure: Multiple Challenges Converge
Structural Challenges Compound Index Pressure
Elevated Selling Activity Points to Concerns
Institutional Hesitation Amid Technical Volatility
Addressing a Critical Market Need
Oxford Lane Capital US6915431026
New $25 Million Share Repurchase Authorization
Revised Annual Guidance Presents Cautious Outlook
Trading Activity Reflects Investor Anxiety
Financial Performance Under Scrutiny
Major Firms Issue Bullish Outlooks
Takeover Proposal Dominates Investor Sentiment
Fundamental Strength Meets Valuation Concerns
Earnings Collapse Triggers Legal Scrutiny
Guidance Shock Triggers Sell-Off
Financial Position and Market Sentiment
Strong Fundamentals Support the Rally
Strategic Moves and Corporate Participation
A Quarter of Significant Losses
Capital Strategy and Debt Restructuring
Guidance Halved Sends Shockwaves
Wall Street Adjusts Outlook Amid Mixed Signals
Strong Institutional Accumulation
Financial Performance and Strategic Positioning
A Vote of Confidence Through Dividend Growth
Strategic Acquisition Strengthens Global Footprint
Key Clinical Data Presentation Nears
A Confirmed Leader Charts the Course
Market Analysts Express Growing Skepticism
Strategic Alliance Targets Supply Chain Innovation
Strong Fundamentals Outweigh Limited Nanjing Impact
A Strategic Partnership and a Live Demonstration
Stellar Quarterly Performance Exceeds Forecasts
Strategic Positioning and Market Reaction
Robust Operational Performance Defies Share Price Weakness ...
A Surge in Sales Amidst Persistent Losses
Market Responds with Enthusiasm
Price Weakness Emerges Amid Declining Volume
Disappointing Earnings Spark Downturn
Broad Sector Caution Contributes to Losses
A Surge Fueled by Social Momentum
Strategic Expansion and Market Performance
Competitive Landscape Intensifies
Market Impact and Technological Significance
Sector-Wide Jitters Weigh on Sentiment
Catastrophic Quarterly Performance
Protecting a Billion-Dollar Brand
Key Clinical Developments Drive Momentum
Strategic Board Expansion Amid Market Turmoil
Executive Expertise for Platform Expansion
Major Dividend Increase Announced
Conflicting Analyst Assessments Create Volatility
Quarterly Performance and Operational Strength
Strategic Initiatives to Drive Customer Traffic
Executive Purchases Contrast With Mixed Institutional Sentiment ...
Financial Performance Reveals Deep Challenges
Institutional Confidence Amid Market Swings
Major Funds Place Significant Bets
Market Expectations and Integration Challenges
Fundamental Pressures Prompt Action
Original-Research: LAIQON AG (von NuWays AG): BUY
Regulatory Decision Sparks Legal Challenges